Hyperactivation of JAK2/STAT3 signaling transduces oncogenic signals to promote CML cells growth, leukemia stem cells survival and therapeutic resistance, thus disease evolution (Stella et al., 2013). Here, JAK2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.